MeiraGTx Holdings (MGTX) Non-Current Assets (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Non-Current Assets of $152.7 million for Q4 2025, down 1.69% on a QoQ basis from $155.3 million in Q3 2025, and up 4.4% year-over-year from $146.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Non-Current Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Non-Current Assets history runs 9 years deep, the most recent figure standing at $152.7 million for Q4 2025.
- Quarterly Non-Current Assets rose 4.4% year-over-year to $152.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $603.7 million (down 3.01% YoY) and the FY2025 annual result came in at $152.7 million, up 4.4% from the prior year.
- Non-Current Assets was $152.7 million for Q4 2025 at MeiraGTx Holdings, down from $155.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $167.1 million in Q4 2023 and bottomed at -$228.4 million in Q1 2021.
- A 5-year average of $30.7 million and a median of $145.2 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets sank 45.22% — and 2024, when it surged 235.17%.
- MeiraGTx Holdings' Non-Current Assets stood at $136.9 million in 2021, then increased by 19.7% to $163.9 million in 2022, then rose by 1.97% to $167.1 million in 2023, then declined by 12.5% to $146.2 million in 2024, then climbed by 4.4% to $152.7 million in 2025.
- Business Quant data shows MGTX's Non-Current Assets at $152.7 million in Q4 2025, $155.3 million in Q3 2025, and $151.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 152.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152.67 Mn |
| Sep 30, 2025 | 155.30 Mn |
| Jun 30, 2025 | 151.63 Mn |
| Mar 31, 2025 | 144.13 Mn |
| Dec 31, 2024 | 146.23 Mn |
| Sep 30, 2024 | 160.44 Mn |
| Jun 30, 2024 | 155.88 Mn |
| Mar 31, 2024 | 159.94 Mn |
| Dec 31, 2023 | 167.12 Mn |
| Sep 30, 2023 | 163.66 Mn |
| Jun 30, 2023 | -140.76 Mn |
| Mar 31, 2023 | -118.32 Mn |
| Dec 31, 2022 | 163.90 Mn |
| Sep 30, 2022 | -147.44 Mn |
| Jun 30, 2022 | -96.93 Mn |
| Mar 31, 2022 | -134.36 Mn |
| Dec 31, 2021 | 136.92 Mn |
| Sep 30, 2021 | -172.90 Mn |
| Jun 30, 2021 | -203.86 Mn |
| Mar 31, 2021 | -228.42 Mn |